Last reviewed · How we verify

NCT04977804

Eccentric Resistance Training With Blood Flow Restriction on Muscle Function

Withdrawn NA Last updated 7 December 2023
What this trial tests

NA trial testing Exercise in Blood Flow Restriction. Withdrawn.

Timeline
30 March 2024
Primary endpoint
1 June 2025
1 December 2025

Quick facts

Lead sponsorUtah State University
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposebasic science
Start date30 March 2024
Primary completion1 June 2025
Estimated completion1 December 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Utah State University

Who can join

Adults 18 to 30, any sex, with Blood Flow Restriction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will determine the effects of adding blood flow restriction to eccentric training to assess whether this increases the improvements of muscle strength and size.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for Blood Flow Restriction

Currently open trials in the same condition.

Other Utah State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04977804.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing